Location: Bentonville, AR
CIK: 0002006045 · Show all filings
Period: Q4 2025 (Next →)
Filing Date: Feb 12, 2026
Total Value: $109M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | 1,280,778 | $21.93M | 20.0% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| VSTM | Verastem Inc | 2,000,000 | $15.44M | 14.1% | $8.91 | 0.0% | COM NEW | 92337C203 |
| AMPG | Aldeyra Therapeutics Inc | 2,555,000 | $13.23M | 12.1% | $3.38 | 0.0% | COM NEW | 03211Q200 |
| PGEN | Precigen Inc | 3,000,000 | $12.54M | 11.5% | $3.87 | 0.0% | COM | 74017N105 |
| IVA | Inventiva S.A. | 2,600,000 | $12.09M | 11.0% | $4.65 | — | ADS | 46124U107 |
| NUVB | Nuvation Bio Inc | 1,250,000 | $11.2M | 10.2% | $6.19 | 0.0% | COM CL A | 67080N101 |
| RANI | Rani Therapeutics Holdings, Inc. | 6,300,000 | $8.505M | 7.8% | $1.51 | 0.0% | COM CL A | 753018100 |
| AARD | Aardvark Therapeutics, Inc. | 476,595 | $6.255M | 5.7% | $12.48 | 0.0% | COM | 002942100 |
| CLNN | Clene Nanomedicine Inc. | 770,495 | $4.523M | 4.1% | $8.31 | 0.0% | COM NEW | 185634201 |
| — | Generation Bio Co | 665,000 | $3.777M | 3.4% | $5.68 | — | COM NEW | 37148K209 |
| SRZNW | Surrozen, Inc. | 150,000 | $3,000 | 0.0% | $0.02 | — | *W EXP 08/01/203 | 86889P117 |